article thumbnail

Bayer: Strong growth, guidance upgrade

The Pharma Data

Earnings were also diminished by a negative product mix, currency effects of 111 million euros, and the later receipt of license revenues. and from a strong allergy season in North America, which resulted in a 15.8 in sales in the Allergy & Cold category. Pharmaceuticals raises sales and earnings. to 4.494 billion euros.

Sales 52
article thumbnail

INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet’s EClinicalMedicine

The Pharma Data

Department of Defense (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in coordination with the Office of the Assistant Secretary of Defense for Health Affairs (OASD(HA)) and the Defense Health Agency (DHA). It will be funded by the U.S.

DNA 40
article thumbnail

Considerations for Mobile Health Technology Developers: Part 2

pharmaphorum

On 27th September 2022, the Food and Drug Administration (FDA) issued its final guidance for industry and FDA staff clinical decision support (CDS) software, which has been anticipated since the Center for Devices and Radiological Health (CDRH) listed the guidance as a top priority for fiscal year 2022.